Skip to main content
Top
Published in: Journal of Clinical Immunology 6/2011

01-12-2011

Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis

Authors: María Eugenia Inzaugarat, Nazarena Eugenia Ferreyra Solari, Luis Ariel Billordo, Raquel Abecasis, Adrian C. Gadano, Alejandra Claudia Cherñavsky

Published in: Journal of Clinical Immunology | Issue 6/2011

Login to get access

Abstract

Nonalcoholic steatohepatitis (NASH) is a chronic inflammatory liver disease associated with insulin resistance and its metabolic consequences. Leukocyte mobilization, intrahepatic activation, and an exacerbated production of reactive oxygen species (ROS) and cytokines contribute to the development of NASH. Though alterations in peripheral blood (PB) T cell proportions and functionality remain unidentified, they might play a main role in NASH progression. We have compared the phenotype and Th1/Th2 commitment of peripheral immune cell reservoirs in adult patients and controls as well as the ability of neutrophils and monocytes to handle an ex vivo challenge. Also, we correlated those parameters with the main histological characteristics in NASH. Compared with controls, patients showed increased numbers of CD4+ cells and both CD4+ and CD8+ CD45RO subsets together with a higher frequency of IFN-γ-producing CD4+ and CD8+ T cells. We also found a decreased number of CD4+ and CD8+ CD45RA subsets. The distinctive production of IFN-γ highlights the significance of the observed skewed frequencies of PB T cells. Whereas ROS production by monocytes from NASH patients did not differ from controls, circulating neutrophils displayed a particularly higher phorbol myristate acetate-induced production of ROS. A negative correlation between oxidative burst and fibrosis grade was observed. This study reveals the presence of a characteristic profile of peripheral immune cells in NASH. We also discuss the probable influence of obesity on some of our present findings.
Literature
1.
go back to reference Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9–19.PubMed Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9–19.PubMed
2.
go back to reference Vuppalanchi R, Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology. 2009;49(1):306–17.PubMedCrossRef Vuppalanchi R, Chalasani N. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Hepatology. 2009;49(1):306–17.PubMedCrossRef
3.
go back to reference Zhan YT, An W. Role of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(37):4652–60.PubMedCrossRef Zhan YT, An W. Role of liver innate immune cells in nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(37):4652–60.PubMedCrossRef
4.
go back to reference Videla L. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol. 2009;1:72–8.PubMedCrossRef Videla L. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms. World J Hepatol. 2009;1:72–8.PubMedCrossRef
5.
go back to reference Pascale A, Pais R, Ratziu V. An overview of nonalcoholic steatohepatitis: past, present and future directions. J Gastrointestin Liver Dis. 2010;19(4):415–23.PubMed Pascale A, Pais R, Ratziu V. An overview of nonalcoholic steatohepatitis: past, present and future directions. J Gastrointestin Liver Dis. 2010;19(4):415–23.PubMed
6.
go back to reference Alberti GMM, Zimmet PM, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.PubMedCrossRef Alberti GMM, Zimmet PM, Shaw J. Metabolic syndrome—a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.PubMedCrossRef
8.
go back to reference Brunt EM. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis. 2005;13(4):533–44.CrossRef Brunt EM. Histopathology of non-alcoholic fatty liver disease. Clin Liver Dis. 2005;13(4):533–44.CrossRef
9.
go back to reference Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132–8.PubMedCrossRef Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol. 2005;42:132–8.PubMedCrossRef
10.
go back to reference Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820–6.PubMed Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology. 2004;40:820–6.PubMed
11.
12.
go back to reference Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(18):2223–6.PubMedCrossRef Basaranoglu M, Kayacetin S, Yilmaz N, Kayacetin E, Tarcin O, Sonsuz A. Understanding mechanisms of the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol. 2010;16(18):2223–6.PubMedCrossRef
13.
go back to reference Jasen PML. Nonalcoholic steatohepatitis. J Med. 2004;62:217–24. Jasen PML. Nonalcoholic steatohepatitis. J Med. 2004;62:217–24.
14.
go back to reference Brunt EA, Kleiner DE, Wilson L, Unalp A, Behling CE, Lavine JE, et al. Portal chronic inflammation in nonalcoholic fatty liver disease. Hepatology. 2009;49(3):809–20.PubMedCrossRef Brunt EA, Kleiner DE, Wilson L, Unalp A, Behling CE, Lavine JE, et al. Portal chronic inflammation in nonalcoholic fatty liver disease. Hepatology. 2009;49(3):809–20.PubMedCrossRef
15.
go back to reference Jaeschke H, Gores GJ, Cederbaum AI, Hinson JÁ, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166–76.PubMedCrossRef Jaeschke H, Gores GJ, Cederbaum AI, Hinson JÁ, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci. 2002;65:166–76.PubMedCrossRef
16.
go back to reference Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002;37:56–62.PubMedCrossRef Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K, Wakasa K. In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. J Hepatol. 2002;37:56–62.PubMedCrossRef
17.
go back to reference Abdelmalek MF, Diehl AM. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discov Today Dis Mech. 2006;3(4):479–88.CrossRef Abdelmalek MF, Diehl AM. Mechanisms underlying nonalcoholic steatohepatitis. Drug Discov Today Dis Mech. 2006;3(4):479–88.CrossRef
18.
go back to reference Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89–97.PubMedCrossRef Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods. 1995;178:89–97.PubMedCrossRef
19.
go back to reference Morel F, Doussiere JV, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem. 1995;201:523–46.CrossRef Morel F, Doussiere JV, Vignais PV. The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur J Biochem. 1995;201:523–46.CrossRef
20.
go back to reference Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.PubMedCrossRef Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.PubMedCrossRef
21.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.PubMedCrossRef Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.PubMedCrossRef
22.
go back to reference World Health Organization (WHO. Preventing and managing the global epidemic of obesity. Report of the World Health Organization Consultation of Obesity. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253. World Health Organization (WHO. Preventing and managing the global epidemic of obesity. Report of the World Health Organization Consultation of Obesity. World Health Organ Tech Rep Ser. 2000;894:i–xii. 1–253.
23.
go back to reference Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology. 2002;106:127–38.PubMedCrossRef Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology. 2002;106:127–38.PubMedCrossRef
24.
go back to reference Linton JP, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector – alterations with aging. Immunol Rev. 1997;160:9–18.PubMedCrossRef Linton JP, Haynes L, Tsui L, Zhang X, Swain S. From naive to effector – alterations with aging. Immunol Rev. 1997;160:9–18.PubMedCrossRef
25.
go back to reference Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002;195(6):789–94.PubMedCrossRef Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med. 2002;195(6):789–94.PubMedCrossRef
26.
go back to reference Richards SJ, Jones RA, Roberts BE, Patel D, Scott CS. Relationships between 2H4 (CD45RA) and UCHLl (CD45RO) expression by normal blood CD4+ CD8−, CD4− CD8+, CD4− CD8dim+, CD3+ CD4−CD8− and CD3− CD4−CD8− lymphocytes. Clin Exp Immunol. 1990;81:149–55.PubMedCrossRef Richards SJ, Jones RA, Roberts BE, Patel D, Scott CS. Relationships between 2H4 (CD45RA) and UCHLl (CD45RO) expression by normal blood CD4+ CD8, CD4 CD8+, CD4 CD8dim+, CD3+ CD4CD8 and CD3 CD4CD8 lymphocytes. Clin Exp Immunol. 1990;81:149–55.PubMedCrossRef
27.
go back to reference Li QF, Li YP, Cheng PS. Peripheral T-lymphocyte subsets changes in patients with endocrine and metabolic diseases. Zhonghua Nei Ke Za Zhi. 1989;28(7):410–2.PubMed Li QF, Li YP, Cheng PS. Peripheral T-lymphocyte subsets changes in patients with endocrine and metabolic diseases. Zhonghua Nei Ke Za Zhi. 1989;28(7):410–2.PubMed
28.
go back to reference Romo EM, Muñoz-Robles JA, Castillo-Rama M, Meneu JC, Moreno-Elola A, Perez-Saborido B, et al. Peripheral blood lymphocyte populations in end-stage liver diseases. J Clin Gastroenterol. 2007;41(7):713–21.PubMedCrossRef Romo EM, Muñoz-Robles JA, Castillo-Rama M, Meneu JC, Moreno-Elola A, Perez-Saborido B, et al. Peripheral blood lymphocyte populations in end-stage liver diseases. J Clin Gastroenterol. 2007;41(7):713–21.PubMedCrossRef
29.
go back to reference Arizcorreta A, Márquez M, Fernández-Gutiérrez C, Guzmán EP, Brun F, Rodríguez-Iglesias M, et al. T cell receptor excision circles (TRECs), CD4+, CD8+ and their CD45RO+ and CD45RA+ subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. Clin Exp Immunol. 2006;146:270–7.PubMedCrossRef Arizcorreta A, Márquez M, Fernández-Gutiérrez C, Guzmán EP, Brun F, Rodríguez-Iglesias M, et al. T cell receptor excision circles (TRECs), CD4+, CD8+ and their CD45RO+ and CD45RA+ subpopulations in hepatitis C virus (HCV)-HIV-co-infected patients during treatment with interferon alpha plus ribavirin: analysis in a population on effective antiretroviral therapy. Clin Exp Immunol. 2006;146:270–7.PubMedCrossRef
30.
go back to reference Leon MP, Spickett G, Jones DEJ, Bassendine MF. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol. 1995;99:233–9.PubMedCrossRef Leon MP, Spickett G, Jones DEJ, Bassendine MF. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol. 1995;99:233–9.PubMedCrossRef
31.
go back to reference Tanigawa T, Iso H, Yamagishi K, Muraki I. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. Atherosclerosis. 2004;173:295–300.PubMedCrossRef Tanigawa T, Iso H, Yamagishi K, Muraki I. Association of lymphocyte sub-populations with clustered features of metabolic syndrome in middle-aged Japanese men. Atherosclerosis. 2004;173:295–300.PubMedCrossRef
32.
go back to reference Yatsuji S, Hashimoto E, Kaneda H, Taniai M, Tokushige K, Shiratori K. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol. 2005;40:1130–8.PubMedCrossRef Yatsuji S, Hashimoto E, Kaneda H, Taniai M, Tokushige K, Shiratori K. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol. 2005;40:1130–8.PubMedCrossRef
33.
go back to reference Bertola A, Bonnafous S, Anty R, Patoraux S, Saint-Pauk MC, Iannelli A, et al. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One. 2010;5(10):e13577.PubMedCrossRef Bertola A, Bonnafous S, Anty R, Patoraux S, Saint-Pauk MC, Iannelli A, et al. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One. 2010;5(10):e13577.PubMedCrossRef
34.
go back to reference Smith SR, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J leukocyte Biology. 1993;54:23–9. Smith SR, Calzetta A, Bankowski J, Kenworthy-Bott L, Terminelli C. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum. J leukocyte Biology. 1993;54:23–9.
35.
go back to reference Maher J, Leon P, Ryan J. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670–8.PubMedCrossRef Maher J, Leon P, Ryan J. Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis. Hepatology. 2008;48:670–8.PubMedCrossRef
36.
go back to reference Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology. 2000;31:633–40.PubMedCrossRef Guebre-Xabier M, Yang S, Lin HZ, Schwenk R, Krzych U, Diehl AM. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers: potential mechanism for sensitization to liver damage. Hepatology. 2000;31:633–40.PubMedCrossRef
37.
go back to reference Wu H, Ghosh S, Perrad XD, Feng L, Garcia GE, Perrad JL, et al. T-Cell accumulation and regulated on activation. normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115:1029–38.PubMedCrossRef Wu H, Ghosh S, Perrad XD, Feng L, Garcia GE, Perrad JL, et al. T-Cell accumulation and regulated on activation. normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115:1029–38.PubMedCrossRef
38.
go back to reference Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1304–10.PubMedCrossRef Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1304–10.PubMedCrossRef
39.
go back to reference Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–55.PubMedCrossRef Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23:549–55.PubMedCrossRef
40.
go back to reference McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, et al. Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem. 2009;284(46):31936–44.PubMedCrossRef McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM, et al. Interferon γ attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem. 2009;284(46):31936–44.PubMedCrossRef
41.
go back to reference Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, Steffensen R, et al. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology. 2009;50(6):1809–17.PubMedCrossRef Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, Steffensen R, et al. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology. 2009;50(6):1809–17.PubMedCrossRef
42.
go back to reference Leclerq LA. Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? Clin Sci. 2004;106:235–7.CrossRef Leclerq LA. Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? Clin Sci. 2004;106:235–7.CrossRef
43.
go back to reference Lefkowitch JH, Haythe JH, Regent N. Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol. 2002;15:699–704.PubMedCrossRef Lefkowitch JH, Haythe JH, Regent N. Kupffer cell aggregation and perivenular distribution in steatohepatitis. Mod Pathol. 2002;15:699–704.PubMedCrossRef
44.
45.
go back to reference Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 2002;100:1869–77.PubMed Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G, et al. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood. 2002;100:1869–77.PubMed
46.
go back to reference Jaeschke H, Smith CV, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 1996;139:213–26.PubMedCrossRef Jaeschke H, Smith CV, Clemens MG, Ganey PE, Roth RA. Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol Appl Pharmacol. 1996;139:213–26.PubMedCrossRef
47.
go back to reference Poniachik J, Csendes A, Díaz JC, Rojas J, Burdiles P, Maluenda F, et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine. 2006;33(5):252–7.PubMedCrossRef Poniachik J, Csendes A, Díaz JC, Rojas J, Burdiles P, Maluenda F, et al. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease. Cytokine. 2006;33(5):252–7.PubMedCrossRef
48.
go back to reference Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology. 2002;35(1):62–73.PubMedCrossRef Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology. 2002;35(1):62–73.PubMedCrossRef
49.
go back to reference Panasiuk A, Wysocka J, Maciorkowska E, Panasiuk B, Prokopowicz D, Zak J, et al. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis. World J Gastroenterol. 2005;11(48):7661–5.PubMed Panasiuk A, Wysocka J, Maciorkowska E, Panasiuk B, Prokopowicz D, Zak J, et al. Phagocytic and oxidative burst activity of neutrophils in the end stage of liver cirrhosis. World J Gastroenterol. 2005;11(48):7661–5.PubMed
50.
go back to reference Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm. 2010;7(15):201. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm. 2010;7(15):201.
Metadata
Title
Altered Phenotype and Functionality of Circulating Immune Cells Characterize Adult Patients with Nonalcoholic Steatohepatitis
Authors
María Eugenia Inzaugarat
Nazarena Eugenia Ferreyra Solari
Luis Ariel Billordo
Raquel Abecasis
Adrian C. Gadano
Alejandra Claudia Cherñavsky
Publication date
01-12-2011
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 6/2011
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-011-9571-1

Other articles of this Issue 6/2011

Journal of Clinical Immunology 6/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.